Biotechblog – Page 1041 – Biotechnology business, policy, and more!

FDA Enforcement Trends: 2007-2008

Guest content from John Avellanet, managing director of Cerulean Associates: The US Food and Drug Administration (FDA) intends to increase […]

At a recent event was recently asked about investment outcomes for venture capitalists. I didn’t have any recent data, so

I’ll be giving a talk on “Career Development in Biotechnology” next week in the AstraZeneca seminar series at the University

Bio-Rad’s got an interesting website up: RethinkPCR. The company’s name isn’t posted on the front page, but is readily available

Today marks the 25th anniversary of the FDA’s approval of the first drug produced by biotechnology, Genentech’s Humulin. I often

I’ve been waiting to write up the Exubera story for the next edition of Building Biotechnology, and the story just

I’ll be speaking at the Biotech for Turkey conference in Istanbul on November 7th. This conference, convened by Bosfor Biotech

A new issue of the Journal of Commercial Biotechnology has just been posted. Drop me a line if you would

Wired has an article on the potential for the pharmaceutical industry to support the international space station, using the microgravity

On the same day that AstraZeneca has announced that it intents to completely outsource all of its drug manufacturing, citing